• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Autosomal dominant Alzheimer's disease. Study of a Moroccan family].

作者信息

Asri F, Moussaoui D, Kadri N

机构信息

Centre Psychiatrique Universitaire Ibn Rochd, Casablanca, Maroc.

出版信息

Encephale. 2003 May-Jun;29(3 Pt 1):254-8.

PMID:12876550
Abstract

The authors describe in this paper a Moroccan family presenting Alzheimer's disease with early onset and rapid course (6 members, of whom 3 died at 34 and 40 years old in a severe picture of dementia). Among these 6 members, Mr M.K., 36 years old, was admitted in the University Psychiatric Department for 4 years of depressive syndrome, -memory impairment and cognitive deficit. In the literature, the cases of Alzheimer's disease begining before 60 years have been reported since 1991; the transmission of this syndrome is autosomal dominant. The genetic studies showed a multifactorial determinism. For the familial cases with early onset, the mutation occurs on the amyloïd precursor protein and on the presenilin 1 and 2. In this case, the result of the familial investigations was compatible with Alzheimer's disease, a dominant autosomic disorder, with early onset between 32 and 40 years old. The clinical course evoked a mutation of presenilin 1. The identification of such mutation in one of his sisters living in France confirmed the genetic transmission. Despite progress made in understanding the pathogenesis, the development of a curative treatment in Alzheimer's disease remains difficult. Selective inhibitors of cholinesterase can improve patients with mild to moderate Alzheimer's disease forms. In Morocco, only donepezil is available, but it is inaccessible for patients who need this treatment because of its high price. For Mr M.K., who still has a professional activity, symptomatic treatment, cognitive and psychological supports may allow him to maintain an adequate life for years. The family support is essential.

摘要

相似文献

1
[Autosomal dominant Alzheimer's disease. Study of a Moroccan family].
Encephale. 2003 May-Jun;29(3 Pt 1):254-8.
2
Three-year follow-up of a patient with early-onset Alzheimer's disease with presenilin-2 N141I mutation - case report and review of the literature.早发性阿尔茨海默病伴早老素2基因N141I突变患者的三年随访——病例报告及文献综述
Eur J Med Res. 2008 Dec 3;13(12):579-84.
3
Novel presenilin mutations within Moroccan patients with Early-Onset Alzheimer's Disease.摩洛哥早发性阿尔茨海默病患者中的新型早老素突变。
Neuroscience. 2014 Jun 6;269:215-22. doi: 10.1016/j.neuroscience.2014.03.052. Epub 2014 Apr 4.
4
Neuropsychological profiles of familial Alzheimer's disease associated with mutations in the presenilin 1 and amyloid precursor protein genes.
J Neurol. 2001 Jan;248(1):45-50. doi: 10.1007/s004150170268.
5
Presenile because of presenilin: the presenilin genes and early onset Alzheimer's disease.早老素所致早老:早老素基因与早发型阿尔茨海默病
Curr Opin Neurol. 1996 Aug;9(4):254-9.
6
[Familial Alzheimer's disease connected with mutation in presenilin gene 1 (P117L)].
Neurol Neurochir Pol. 2001 Mar-Apr;35(2):213-24.
7
[Presenilin-1 (S182) causative gene of early-onset familial Alzheimer's disease].
Tanpakushitsu Kakusan Koso. 1996 Aug;41(10):1441-7.
8
The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease.早发性阿尔茨海默病遗传学的已解与未解之谜。
Neuromolecular Med. 2002;2(1):1-10. doi: 10.1385/NMM:2:1:01.
9
No detected mutations in the genes for the amyloid precursor protein and presenilins 1 and 2 in a swiss early-onset Alzheimer's disease family with a dominant mode of inheritance.在一个具有显性遗传模式的瑞士早发性阿尔茨海默病家族中,淀粉样前体蛋白基因以及早老素1和早老素2基因未检测到突变。
Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):431-6. doi: 10.1159/000017185.
10
Alzheimer's disease.
Perspect Biol Med. 1997 Winter;40(2):230-45. doi: 10.1353/pbm.1997.0020.